Tadashi Maekawa

854 total citations
42 papers, 468 citations indexed

About

Tadashi Maekawa is a scholar working on Genetics, Hematology and Molecular Biology. According to data from OpenAlex, Tadashi Maekawa has authored 42 papers receiving a total of 468 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Genetics, 15 papers in Hematology and 10 papers in Molecular Biology. Recurrent topics in Tadashi Maekawa's work include Acute Myeloid Leukemia Research (10 papers), Hemoglobinopathies and Related Disorders (7 papers) and Acute Lymphoblastic Leukemia research (6 papers). Tadashi Maekawa is often cited by papers focused on Acute Myeloid Leukemia Research (10 papers), Hemoglobinopathies and Related Disorders (7 papers) and Acute Lymphoblastic Leukemia research (6 papers). Tadashi Maekawa collaborates with scholars based in Japan. Tadashi Maekawa's co-authors include M Takada, Hiroshi Tanaka, Norio Kobayashi, Shigeru Oguma, Yataro Yoshida, Takeo Nomura, Masami Azuma, Haruto Uchino, Hideaki Mizoguchi and Kiku Nakao and has published in prestigious journals such as Blood, Cancer and Analytical Biochemistry.

In The Last Decade

Tadashi Maekawa

39 papers receiving 442 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tadashi Maekawa Japan 11 276 96 94 85 67 42 468
L.C. Chan Hong Kong 14 262 0.9× 145 1.5× 133 1.4× 34 0.4× 47 0.7× 26 598
Helen Enright Ireland 14 345 1.3× 81 0.8× 140 1.5× 44 0.5× 91 1.4× 41 625
S. C. Tso China 13 192 0.7× 39 0.4× 162 1.7× 35 0.4× 43 0.6× 24 473
C D Hillyer United States 8 333 1.2× 56 0.6× 58 0.6× 89 1.0× 23 0.3× 10 478
Irving Innerfield United States 15 124 0.4× 58 0.6× 52 0.6× 29 0.3× 51 0.8× 53 562
Mirjana Mitrović Serbia 11 250 0.9× 150 1.6× 68 0.7× 35 0.4× 37 0.6× 54 436
Irving B. Mink United States 14 167 0.6× 70 0.7× 63 0.7× 40 0.5× 49 0.7× 25 639
F García‐Bragado Spain 8 233 0.8× 36 0.4× 155 1.6× 21 0.2× 106 1.6× 29 474
C. Gardikas Greece 12 116 0.4× 66 0.7× 81 0.9× 27 0.3× 37 0.6× 56 395
Francesca Marangoni Italy 9 387 1.4× 22 0.2× 86 0.9× 22 0.3× 64 1.0× 18 577

Countries citing papers authored by Tadashi Maekawa

Since Specialization
Citations

This map shows the geographic impact of Tadashi Maekawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tadashi Maekawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tadashi Maekawa more than expected).

Fields of papers citing papers by Tadashi Maekawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tadashi Maekawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tadashi Maekawa. The network helps show where Tadashi Maekawa may publish in the future.

Co-authorship network of co-authors of Tadashi Maekawa

This figure shows the co-authorship network connecting the top 25 collaborators of Tadashi Maekawa. A scholar is included among the top collaborators of Tadashi Maekawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tadashi Maekawa. Tadashi Maekawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kobayashi, Norio, et al.. (2015). Criteria for Diagnosis of DIC Based on the Analysis of Clinical and Laboratory Findings in 345 DIC Patients Collected by the Research Committee on DIC in Japan. Current studies in hematology and blood transfusion. 265–275. 108 indexed citations
2.
Oguma, Shigeru, Yataro Yoshida, Minoru Okuma, et al.. (1997). Mode of disease progression in primary myelodysplastic syndromes: A Japanese co-operative study. Leukemia Research. 21(3). 241–247. 1 indexed citations
3.
Oguma, Shigeru, et al.. (1995). Clinical characteristics of Japanese patients with primary myelodysplastic syndromes: A co-operative study based on 838 cases. Leukemia Research. 19(3). 219–225. 53 indexed citations
4.
Nagura, E, Kiyoji Kimura, Kazumasa Yamada, et al.. (1994). Nation-wide randomized comparative study of doxorubicin, vincristine and prednisolone combination therapy with and without L-asparaginase for adult acute lymphoblastic leukemia. Cancer Chemotherapy and Pharmacology. 33(5). 359–365. 4 indexed citations
5.
Nagura, E, Kiyoji Kimura, Kazumasa Yamada, et al.. (1994). Nation-wide randomized comparative study of doxorubicin, vincristine and prednisolone combination therapy with and without L-asparaginase for adult acute lymphoblastic leukemia. Cancer Chemotherapy and Pharmacology. 33(5). 359–365. 31 indexed citations
6.
7.
Yoshida, Yataro, Shigeru Oguma, Haruto Uchino, Tadashi Maekawa, & Takeo Nomura. (1992). Clinical features of long-term survivors of refractory myelodysplastic anemias. A Japanese cooperative study. Leukemia Research. 16(8). 775–779. 5 indexed citations
8.
Uchiyama, Toshimasa, et al.. (1990). One-Stage Method for Assay of Tissue Factor Activity of Leukemic Cell with Special Reference to Disseminated Intravascular Coagulation. American Journal of Clinical Pathology. 93(5). 679–684. 6 indexed citations
9.
Kimura, Kiyoji, Ryuzo Ohno, Kenichi Hattori, et al.. (1986). Phase I clinical and pharmacokinetic study ofN 4-behenoyl-1-β-d-arabinofuranosylcytosine. Medical Oncology and Tumor Pharmacotherapy. 3(1). 5 indexed citations
10.
Karasawa, Masamitsu, et al.. (1986). Methionine partially corrects the impaired deoxyribonucleic acid synthesis of B12-deficient magaloblastic bone marrow cells at low concentration.. Japanese Journal of Medicine. 25(2). 155–161. 4 indexed citations
11.
Maekawa, Tadashi, et al.. (1981). Acceleration of allogeneic antitumor immunity with immune RNA in vitro and T-cell suppression by L1210 tumor bearer spleen cells.. PubMed. 41(2). 383–98. 1 indexed citations
12.
Tanaka, Hiroshi, et al.. (1979). Studies on Antithrombin III (AT III). Blood & Vessel. 10(1). 59–62. 1 indexed citations
13.
Omine, Mitsuhiro, et al.. (1978). Altered DNA sedimentation by the presence of erythrocytes in alkaline sucrose gradient centrifugation. Analytical Biochemistry. 89(2). 337–342. 1 indexed citations
14.
Kobayashi, Norio, et al.. (1978). Studies on antithrombin III. Purfication of canine antithrombin III and its properties. Blood & Vessel. 9(1). 139–144. 1 indexed citations
15.
Arai, Hitoshi, et al.. (1976). Study on Normotest (Hepaplastin test). Blood & Vessel. 7(2). 111–118. 1 indexed citations
16.
Kobayashi, Norio & Tadashi Maekawa. (1974). Studies on the Shape Change in Rabbit Platelets Induced by Adenosine Diphosphate or Several Metabolic Inhibitors. Thrombosis and Haemostasis. 31(1). 179–186.
17.
Azuma, Masami, et al.. (1970). A study on the erythropoiesis stimulating effect of the thyroid hormone. Annals of Hematology. 21(4). 240–243. 1 indexed citations
19.
Nakao, Kiku, et al.. (1967). Studies on Erythropoietic Action of Angiotensin II. Blood. 29(5). 754–760. 35 indexed citations
20.
Hasegawa, Toru, et al.. (1959). Studies on Serological Differentiation Between Tissue and Plasma Thromboplastin. Acta Haematologica. 22(4). 232–239. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026